Vistagen Therapeutics Inc (VTGN)
4.50
+0.09
(+2.04%)
USD |
NASDAQ |
May 03, 16:00
4.49
-0.01
(-0.22%)
After-Hours: 20:00
Vistagen Therapeutics Price to Book Value: 0.9864 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.9864 |
| May 02, 2024 | 0.9667 |
| May 01, 2024 | 1.039 |
| April 30, 2024 | 1.059 |
| April 29, 2024 | 1.046 |
| April 26, 2024 | 1.041 |
| April 25, 2024 | 1.030 |
| April 24, 2024 | 1.035 |
| April 23, 2024 | 1.059 |
| April 22, 2024 | 1.048 |
| April 19, 2024 | 1.043 |
| April 18, 2024 | 1.030 |
| April 17, 2024 | 1.024 |
| April 16, 2024 | 1.019 |
| April 15, 2024 | 1.041 |
| April 12, 2024 | 1.072 |
| April 11, 2024 | 1.163 |
| April 10, 2024 | 1.118 |
| April 09, 2024 | 1.177 |
| April 08, 2024 | 1.133 |
| April 05, 2024 | 1.105 |
| April 04, 2024 | 1.160 |
| April 03, 2024 | 1.179 |
| April 02, 2024 | 1.184 |
| April 01, 2024 | 1.184 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.157 |
| March 27, 2024 | 1.002 |
| March 26, 2024 | 0.9536 |
| March 25, 2024 | 0.9382 |
| March 22, 2024 | 0.9141 |
| March 21, 2024 | 0.924 |
| March 20, 2024 | 0.9141 |
| March 19, 2024 | 0.9097 |
| March 18, 2024 | 0.89 |
| March 15, 2024 | 0.8878 |
| March 14, 2024 | 0.8593 |
| March 13, 2024 | 0.9207 |
| March 12, 2024 | 0.8966 |
| March 11, 2024 | 0.9141 |
| March 08, 2024 | 0.9229 |
| March 07, 2024 | 0.9284 |
| March 06, 2024 | 0.9711 |
| March 05, 2024 | 0.9843 |
| March 04, 2024 | 1.063 |
| March 01, 2024 | 1.111 |
| February 29, 2024 | 1.120 |
| February 28, 2024 | 1.142 |
| February 27, 2024 | 1.160 |
| February 26, 2024 | 1.106 |
| February 23, 2024 | 1.083 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6358
Minimum
Dec 28 2022
57.55
Maximum
Dec 30 2020
5.208
Average
3.564
Median
Price to Book Value Benchmarks
| Ardelyx Inc | 12.16 |
| Axsome Therapeutics Inc | 18.56 |
| Vir Biotechnology Inc | 0.8823 |
| Immuneering Corp | 0.5369 |
| NovaBay Pharmaceuticals Inc | 2.094 |
Price to Book Value Related Metrics
| PS Ratio | 58.25 |
| Price | 4.50 |
| Earnings Yield | -77.98% |
| Market Cap | 121.61M |